Authors:
Kuo, YM
Beach, TG
Sue, LI
Scott, S
Layne, KJ
Kokjohn, TA
Kalback, WM
Luehrs, DC
Vishnivetskaya, TA
Abramowski, D
Sturchler-Pierrat, C
Staufenbiel, M
Weller, RO
Roher, AE
Citation: Ym. Kuo et al., The evolution of A beta peptide burden in the APP23 transgenic mice: Implications for A beta deposition in Alzheimer disease, MOL MED, 7(9), 2001, pp. 609-618
Citation: Ro. Weller, How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer's diseases?, J PATHOLOGY, 194(1), 2001, pp. 1-3
Authors:
Kuo, YM
Crawford, F
Mullan, M
Kokjohn, TA
Emmerling, MR
Weller, RO
Roher, AE
Citation: Ym. Kuo et al., Elevated A beta and apolipoprotein E in A beta PP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease, MOL MED, 6(5), 2000, pp. 430-439
Authors:
Sun, D
Tani, M
Newman, TA
Krivacic, K
Phillips, M
Chernosky, A
Gill, P
Wei, T
Griswold, KJ
Ransohoff, RM
Weller, RO
Citation: D. Sun et al., Role of chemokines, neuronal projections, and the blood-brain barrier in the enhancement of cerebral EAE following focal brain damage, J NE EXP NE, 59(12), 2000, pp. 1031-1043
Authors:
Honeybul, S
Neil-Dwyer, G
Lang, DA
Evans, BT
Weller, RO
Gill, J
Citation: S. Honeybul et al., The extended transbasal approach: A quantitative anatomical and histological study, ACT NEUROCH, 141(3), 1999, pp. 251-259
Citation: Ro. Weller, Intraspinal primitive neuroectodermal tumour: Report of two cases and review of the literature - Comment, ACT NEUROCH, 141(11), 1999, pp. 1175-1175